Table 1 Characteristics of three European cohorts
Cohort n = number tested for HLA-B*27 | HLA-B*27 n (%) | Median age at onset (years) | Median follow up (years) | Multifocal n (%) | Male n (%) | Psoriasis n (%) | Arthritis n (%) | IBD n (%) |
|---|---|---|---|---|---|---|---|---|
Germany n = 476 | 79 (16.5) | 10.34 | 2.49 | 291 (61) | 173 (36.4) | 32 (6.7) | 88 (18.5) | 17 (3.6) |
Ireland n = 50 | 10 (20) | 9.23 | 2.75 | 46 (92) | 14 (28) | 9 (18) | 9 (18) | 1 (2) |
Bristol n = 46 | 6 (13) | 10.0 | 2.35 | 39 (87) | 13 (28.3) | 3 (6.5) | 8 (17.4) | 0 (0) |